ABCC6 deficiency is associated with activation of BMP signaling in liver and kidney

FEBS Open Bio

Volumn 5, Issue , 2015, Pages 257-263

  Blazquez Medela, Ana M ^a   Guihard, Pierre J ^a   Yao, Jiayi ^a   Jumabay, Medet ^a   Lusis, Aldons J ^a,b   Boström, Kristina I ^a,b   Yao, Yucheng ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

ATP binding cassette sub family C member 6 (ABCC6); BMP signaling; Bone morphogenetic protein (BMP); Kidney; Liver; Mouse

Indexed keywords

ACTIVIN RECEPTOR LIKE KINASE 1; ACTIVIN RECEPTOR LIKE KINASE 2; BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; CV2 PROTEIN; HEAT SHOCK PROTEIN 70; MGP PROTEIN; NOGGIN; PROTEIN; PROTEIN SERINE THREONINE KINASE; SMAD2 PROTEIN; SMAD3 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA; ARTICLE; BLOOD VESSEL CALCIFICATION; CONTROLLED STUDY; GENE DELETION; GENE MUTATION; HEART; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; KIDNEY; LIVER; LUNG; MOUSE; MULTIDRUG RESISTANCE ASSOCIATED PROTEIN 6 DEFICIENCY; MUSCLE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TRANSGENE;

MUS;

EID: 84926459708     PISSN: 22115463     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fob.2015.03.009     Document Type: Article

References (37)

1. Beck K., Hayashi K., Nishiguchi B., Le Saux O., Hayashi M., Boyd C.D. The distribution of Abcc6 in normal mouse tissues suggests multiple functions for this ABC transporter. J. Hisochem. Cytochem. 2003, 51:887-902.
2. Le Saux O., et al. Mutations in a gene encoding an ABC transporter cause pseudoxanthoma elasticum. Nat. Genet. 2000, 25:223-227.
3. Plomp A.S., Toonstra J., Bergen A.A., van Dijk M.R., de Jong P.T. Proposal for updating the pseudoxanthoma elasticum classification system and a review of the clinical findings. Am. J. Med. Genet. Part A 2010, 152A:1049-1058.
4. Gorgels T.G., et al. Disruption of Abcc6 in the mouse: novel insight in the pathogenesis of pseudoxanthoma elasticum. Hum. Mol. Genet. 2005, 14:1763-1773.
5. Kauffenstein G., et al. Disseminated arterial calcification and enhanced myogenic response are associated with abcc6 deficiency in a mouse model of pseudoxanthoma elasticum. Arterioscler. Thromb. Vasc. Biol. 2014, 34:1045-1056.
6. Jiang Q., Oldenburg R., Otsuru S., Grand-Pierre A.E., Horwitz E.M., Uitto J. Parabiotic heterogenetic pairing of Abcc6-/-/Rag1-/- mice and their wild-type counterparts halts ectopic mineralization in a murine model of pseudoxanthoma elasticum. Am. J. Pathol. 2010, 176:1855-1862.
7. Hosen M.J., Coucke P.J., Le Saux O., De Paepe A., Vanakker O.M. Perturbation of specific pro-mineralizing signalling pathways in human and murine pseudoxanthoma elasticum. Orphanet. J. Rare Dis. 2014, 9:66.
8. Meng H., et al. Identification of Abcc6 as the major causal gene for dystrophic cardiac calcification in mice through integrative genomics. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:4530-4535.
9. Wallin R., Cain D., Hutson S.M., Sane D.C., Loeser R. Modulation of the binding of matrix Gla protein (MGP) to bone morphogenetic protein-2 (BMP-2). Thromb. Haemost. 2000, 84:1039-1044.
10. Yao Y., Shahbazian A., Bostrom K.I. Proline and gamma-carboxylated glutamate residues in matrix Gla protein are critical for binding of bone morphogenetic protein-4. Circ. Res. 2008, 102:1065-1074.
11. Yao Y., Jumabay M., Wang A., Bostrom K.I. Matrix Gla protein deficiency causes arteriovenous malformations in mice. J. Clin. Invest. 2011, 121:2993-3004.
12. Hendig D., Zarbock R., Szliska C., Kleesiek K., Gotting C. The local calcification inhibitor matrix Gla protein in pseudoxanthoma elasticum. Clin. Biochem. 2008, 41:407-412.
13. Uitto J., Li Q., Jiang Q. Pseudoxanthoma elasticum: molecular genetics and putative pathomechanisms. J. Invest. Dermatol. 2010, 130:661-670.
14. Wallin R., Cain D., Sane D.C. Matrix Gla protein synthesis and gamma-carboxylation in the aortic vessel wall and proliferating vascular smooth muscle cells - a cell system which resembles the system in bone cells. Thromb. Haemost. 1999, 82:1764-1767.
15. Mungrue I.N., et al. Abcc6 deficiency causes increased infarct size and apoptosis in a mouse cardiac ischemia-reperfusion model. Arterioscler. Thromb. Vasc. Biol. 2011, 31:2806-2812.
16. Yao Y., Zebboudj A.F., Shao E., Perez M., Bostrom K. Regulation of bone morphogenetic protein-4 by matrix GLA protein in vascular endothelial cells involves activin-like kinase receptor 1. J. Biol. Chem. 2006, 281:33921-33930.
17. Jumabay M., et al. Endothelial differentiation in multipotent cells derived from mouse and human white mature adipocytes. J. Mol. Cell. Cardiol. 2012, 53:790-800.
18. Qiao J.H., Xie P.Z., Fishbein M.C., Kreuzer J., Drake T.A., Demer L.L., Lusis A.J. Pathology of atheromatous lesions in inbred and genetically engineered mice. Genetic determination of arterial calcification. Arterioscler. Thromb. 1994, 14:1480-1497.
19. Bostrom K.I., Jumabay M., Matveyenko A., Nicholas S.B., Yao Y. Activation of vascular bone morphogenetic protein signaling in diabetes mellitus. Circ. Res. 2010, 108:446-457.
20. Bostrom K., Tsao D., Shen S., Wang Y., Demer L.L. Matrix GLA protein modulates differentiation induced by bone morphogenetic protein-2 in C3H10T1/2 cells. J. Biol. Chem. 2001, 276:14044-14052.
21. Aherrahrou Z., et al. An alternative splice variant in Abcc6, the gene causing dystrophic calcification, leads to protein deficiency in C3H/He mice. J. Biol. Chem. 2008, 283:7608-7615.
22. Yao Y., Shao E.S., Jumabay M., Shahbazian A., Ji S., Bostrom K.I. High-density lipoproteins affect endothelial BMP-signaling by modulating expression of the activin-like kinase receptor 1 and 2. Arterioscler. Thromb. Vasc. Biol. 2008, 28:2266-2274.
23. Yao Y., Jumabay M., Ly A., Radparvar M., Wang A.H., Abdmaulen R., Bostrom K.I. Crossveinless 2 regulates bone morphogenetic protein 9 in human and mouse vascular endothelium. Blood 2012, 119:5037-5047.
24. Yao Y., Watson A.D., Ji S., Bostrom K.I. Heat shock protein 70 enhances vascular bone morphogenetic protein-4 signaling by binding matrix Gla protein. Circ. Res. 2009, 105:575-584.
25. Miriyala S., Gongora Nieto M.C., Mingone C., Smith D., Dikalov S., Harrison D.G., Jo H. Bone morphogenic protein-4 induces hypertension in mice: role of noggin, vascular NADPH oxidases, and impaired vasorelaxation. Circulation 2006, 113:2818-2825.
26. Sorescu G.P., et al. Bone morphogenic protein 4 produced in endothelial cells by oscillatory shear stress stimulates an inflammatory response. J. Biol. Chem. 2003, 278:31128-31135.
27. Csiszar A., Smith K.E., Koller A., Kaley G., Edwards J.G., Ungvari Z. Regulation of bone morphogenetic protein-2 expression in endothelial cells: role of nuclear factor-kappaB activation by tumor necrosis factor-alpha, H2O2, and high intravascular pressure. Circulation 2005, 111:2364-2372.
28. David L., Feige J.J., Bailly S. Emerging role of bone morphogenetic proteins in angiogenesis. Cytokine Growth Factor Rev. 2009, 20:203-212.
29. Bostrom K.I., Rajamannan N.M., Towler D.A. The regulation of valvular and vascular sclerosis by osteogenic morphogens. Circ. Res. 2011, 109:564-577.
30. Moura J., da Silva L., Cruz M.T., Carvalho E. Molecular and cellular mechanisms of bone morphogenetic proteins and activins in the skin: potential benefits for wound healing. Arch. Dermatol. Res. 2013, 305:557-569.
31. Wordinger R.J., Clark A.F. Bone morphogenetic proteins and their receptors in the eye. Exp. Biol. Med. 2007, 232:979-992.
32. Pomozi V., et al. ABCC6 is a basolateral plasma membrane protein. Circ. Res. 2013, 112:e148-e151.
33. Martin L.J., et al. ABCC6 localizes to the mitochondria-associated membrane. Circ. Res. 2012, 111:516-520.
34. Dabisch-Ruthe M., Kuzaj P., Gotting C., Knabbe C., Hendig D. Pyrophosphates as a major inhibitor of matrix calcification in Pseudoxanthoma elasticum. J. Dermatol. Sci. 2014, 75:109-120.
35. Jansen R.S., et al. ATP-binding cassette subfamily C member 6-mediated ATP secretion by the liver is the main source of the mineralization inhibitor inorganic pyrophosphate in the systemic circulation. Arterioscler. Thromb. Vasc. Biol. 2014, 34:1985-1989.
36. Li X., Yang H.Y., Giachelli C.M. BMP-2 promotes phosphate uptake, phenotypic modulation, and calcification of human vascular smooth muscle cells. Atherosclerosis 2008, 199:271-277.
37. Tada H., Nemoto E., Foster B.L., Somerman M.J., Shimauchi H. Phosphate increases bone morphogenetic protein-2 expression through cAMP-dependent protein kinase and ERK1/2 pathways in human dental pulp cells. Bone 2011, 48:1409-1416.